Imago BioSciences Appoints Enoch Kariuki to Board of Directors

South San Francisco, Calif. – Feb. 2, 2021 – Imago BioSciences, Inc. (Imago), a clinical stage biopharmaceutical company developing innovative treatments for myeloid diseases, today announced that

Imago BioSciences Appoints Matthew J. Plunkett as Chief Financial Officer

South San Francisco, Calif. – January 19, 2021 – Imago BioSciences, Inc. (Imago), a clinical stage biopharmaceutical company developing innovative treatments for myeloid diseases, today announced the appointment

Imago BioSciences to Present at the 39th Annual J.P. Morgan Healthcare Conference

South San Francisco, CA, – January 12, 2021 – Imago BioSciences, Inc., a clinical-stage biopharmaceutical company developing innovative treatments for myeloproliferative neoplasms, today announced that